| Financial Year |
March 31 2023 |
| Monetary Funds |
1,659,385,125.58 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
54,557,163.80 |
| Accounts Receivable |
1,071,573,990.51 |
| Advances to Suppliers |
66,719,701.00 |
| Other Receivables |
118,683,687.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,617,927,574.35 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
48,619,850.34 |
| Total Current Assets |
5,287,679,480.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
3,459,752,046.54 |
| Under-construction Projects |
100,618,555.67 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
302,650,979.28 |
| R&D expenses |
-- |
| Goodwill |
8,123,257.36 |
| Long-Term Deferred and Prepaid Expenses |
43,833,984.13 |
| Deferred Income Tax Assets |
183,915,276.23 |
| Other Non-Current Assets |
240,960,459.52 |
| Sub-Total of Non-Current Assets |
4,515,801,003.56 |
| Total Assets |
9,803,480,484.25 |
| Short-Term Loans |
340,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
791,723,060.21 |
| Accounts Payable |
1,099,929,302.08 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
63,969,246.45 |
| Taxes Payable |
61,934,306.44 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
447,599,584.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
385,224,336.92 |
| Other Current Liabilities |
532,951,028.69 |
| Sub-Total of Current Liabilities |
3,809,452,650.43 |
| Long-term Loans |
1,317,402,936.39 |
| Bonds Payable |
1,032,822,562.27 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,289,516.72 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,441,372,546.77 |
| Total Liabilities |
6,250,825,197.20 |
| Paid-In Capital(Or Share Stock) |
415,179,242.00 |
| Capital Surplus |
1,368,472,734.49 |
| Surplus Reserve |
160,048,197.71 |
| LESS:Treasury Stock |
110,003,060.39 |
| Undistributed Profits |
1,232,091,005.69 |
| Minority Stockholder's Interest |
294,976,767.99 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,257,678,519.06 |
| Owner's Equity（Stockholder's Equity） |
3,552,655,287.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,803,480,484.25 |
